| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/11/2012 | US8263133 Multivalent clustering targeting strategy for drug carriers |
| 09/11/2012 | US8263089 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/11/2012 | US8263080 Use of agonists and antagonists of IL-23 in the treatment of viral infection |
| 09/11/2012 | US8263068 Modified cells expressing a protein that modulates activity of bHLH proteins, and uses thereof |
| 09/11/2012 | US8263067 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 09/11/2012 | US8263066 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 09/11/2012 | CA2510180C Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
| 09/11/2012 | CA2491726C Feline infectious peritonitis vaccine |
| 09/11/2012 | CA2451577C Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 09/11/2012 | CA2448123C Taci-immunoglobulin fusion proteins |
| 09/11/2012 | CA2423004C Peptide inhibitors of hiv entry |
| 09/11/2012 | CA2374180C Methods and materials for generating sh3 domains with tailored binding properties |
| 09/11/2012 | CA2326407C Retroviral vectors including modified envelope escort proteins |
| 09/11/2012 | CA2272820C An improved method for the production and purification of adenoviral vectors |
| 09/11/2012 | CA2254082C Metastatic colorectal cancer vaccine |
| 09/11/2012 | CA2233867C Vector and method of use for nucleic acid delivery to non-dividing cells |
| 09/07/2012 | WO2012119095A1 Fus1/tusc2 therapies |
| 09/07/2012 | WO2012119051A2 Enhanced biodistribution of oligomers |
| 09/07/2012 | WO2012118915A2 Compositions and methods for treatment of tamoxifen resistant breast cancer |
| 09/07/2012 | WO2012118092A1 Fusion protein |
| 09/07/2012 | WO2012116636A1 Oncolytic adenovirus for target therapy of human tumor and use thereof |
| 09/07/2012 | WO2012116621A1 Optically controlled gene expression system |
| 09/07/2012 | CA2864394A1 Fus1/tusc2 therapies |
| 09/07/2012 | CA2827533A1 Enhanced biodistribution of oligomers |
| 09/06/2012 | US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 09/06/2012 | US20120225930 Method of treating or retarding the development of blindness |
| 09/06/2012 | US20120225084 Klf family members regulate intrinsic axon regeneration ability |
| 09/06/2012 | US20120225082 ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis |
| 09/06/2012 | US20120225045 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 09/06/2012 | US20120225014 Antibodies to cd40 |
| 09/05/2012 | EP2495327A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 09/05/2012 | EP2495323A1 Modified double-stranded polynucleotide |
| 09/05/2012 | EP2494993A2 Amino acid lipids and uses thereof |
| 09/05/2012 | EP2494977A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 09/05/2012 | EP2494058A1 Cardiac-specific nucleic acid regulatory elements and methods and use thereof |
| 09/05/2012 | CN1984996B Replication competent viruses capable of silencing virus inhibitory factor expression |
| 09/05/2012 | CN1738911B Solid surface for biomolecule delivery and high-throughput assay |
| 09/05/2012 | CN1639569B Methods and compositions for inducing an immune response |
| 09/05/2012 | CN102653762A Gene with function of inhibiting proliferation of gastric cancer cell BGC-823 and preparation method of gene |
| 09/05/2012 | CN102653554A Functional mycobacterium tuberculosis antigen polypeptide and application thereof |
| 09/05/2012 | CN102652837A Medicament for treating colorectal cancer |
| 09/05/2012 | CN101906404B Avian infectious bronchitis virus (IBV) as well as culture method and application thereof |
| 09/05/2012 | CN101891803B New cartilaginous affinity polypeptide sequence, screening method and application thereof |
| 09/05/2012 | CN101775399B Asia1 type multi-epitope recombinant vaccine of bovine foot-and-mouth disease viruses and preparation method thereof |
| 09/05/2012 | CN101709292B Recombinant adenovirus, and preparation method and application thereof |
| 09/05/2012 | CN101693890B Immunostimulatory sequence oligonucleotides and methods of using the same |
| 09/05/2012 | CN101671397B Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof |
| 09/05/2012 | CN101638652B RNA interfering target of osteoclast V-ATP enzyme proton pump sub-unit ATP6vlcl and application thereof |
| 09/05/2012 | CN101460627B Process for producing poxviruses and poxvirus compositions |
| 09/05/2012 | CN101426535B DNA virus microrna and methods for inhibiting same |
| 09/05/2012 | CN101014613B Chimpanzee adenovirus vaccine carriers |
| 09/05/2012 | CN101006172B Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
| 09/04/2012 | US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA) |
| 09/04/2012 | US8258114 Modulation of glucose-6-phosphatase translocase expression |
| 09/04/2012 | US8258111 Compositions and methods related to miRNA modulation of neovascularization or angiogenesis |
| 09/04/2012 | US8258106 Immunostimulatory nucleic acid molecules |
| 09/04/2012 | US8258105 Antisense oligonucleotides optimized for kidney targeting |
| 09/04/2012 | US8257927 Hereditary hemochromatosis gene |
| 09/04/2012 | US8257717 Immunogenic polypeptides encoded by MAGE minigenes and uses thereof |
| 09/04/2012 | US8257692 Polypeptide having an improved cytosine deaminase activity |
| 09/04/2012 | US8257686 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 09/04/2012 | CA2528411C Method for improving stability and shelf-life of liposome complexes |
| 09/04/2012 | CA2520279C Mutant vesicular stomatitis viruses and use thereof |
| 09/04/2012 | CA2471812C Targeted retrograde gene delivery to motor neurons |
| 09/04/2012 | CA2432971C Polypeptides |
| 09/04/2012 | CA2318374C Human suppressor trna oligonucleotides and methods of use for same |
| 09/04/2012 | CA2295865C Method for diagnosing alzheimer disease |
| 09/04/2012 | CA2243261C Methods for delivering dna to muscle cells using recombinant adeno-associated virus virions |
| 08/30/2012 | WO2012116357A2 Use of agr3 for treating cancer |
| 08/30/2012 | WO2012116282A2 Protein nanocarriers for topical delivery |
| 08/30/2012 | WO2012116210A2 Peptide for the induction of immune tolerance as treatment for systemic lupus erythematosus |
| 08/30/2012 | WO2012116142A2 Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv |
| 08/30/2012 | WO2012116064A1 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes |
| 08/30/2012 | WO2012115987A2 Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock |
| 08/30/2012 | WO2012115437A2 Pharmaceutical composition for cancer treatment or metastasis inhibition containing expression or activation inhibitors of map7d2 protein, novel cancer therapeutic target |
| 08/30/2012 | WO2012115185A1 Composition for treatment, amelioration or prophylaxis of pain |
| 08/30/2012 | WO2012114131A1 Lecithin:cholesterol acyltransferase (lcat) and its role in nonalcoholic fatty liver disease (nafld) |
| 08/30/2012 | WO2012113859A1 Modified pig islets for diabetes treatment |
| 08/30/2012 | WO2012113236A1 Use and method of hepatocyte nuclear factor 1α for treating chronic liver diseases |
| 08/30/2012 | WO2012094081A3 System and method for identifying and applying peripheral treatment mechanisms for disease |
| 08/30/2012 | WO2010121074A8 Modulation of inflammatory responses by factor xi |
| 08/30/2012 | US20120220646 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/30/2012 | US20120220492 Viral Vectors with Improved Properties |
| 08/30/2012 | US20120219632 Methods for monitoring cellular states and for immortalizing mesenchymal stem cell |
| 08/30/2012 | US20120219578 Neisserial antigenic peptides |
| 08/30/2012 | US20120219544 Adhesive composition for soft tissues, adhesive composition for wound dressing or wound dressing composition |
| 08/30/2012 | US20120219528 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 08/30/2012 | US20120219497 Random ethylene oxide and non-random alkylene oxide(s) polymers |
| 08/30/2012 | CA2828443A1 Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv |
| 08/30/2012 | CA2828255A1 Protein nanocarriers for topical delivery |
| 08/30/2012 | CA2828229A1 Recombinant mumps virus vaccine |
| 08/30/2012 | CA2827329A1 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes |
| 08/29/2012 | EP2492282A1 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 08/29/2012 | EP2491123A2 Single molecule nucleic acid nanoparticles |
| 08/29/2012 | EP2490724A2 Compositions for improving migration potential of stem cells |
| 08/29/2012 | EP2008664B1 Modified proteins which bind extracellular matrix components |
| 08/29/2012 | CN1636594B Angiostatin and use of the same for inhibition of angiogenesis |
| 08/29/2012 | CN102649978A Application of CCDC158 gene in preparation of drugs for treating or diagnosing liver cancer |
| 08/29/2012 | CN102649963A Human papillomavirus (HPV) L1-based recombinant adenovirus for preventing and treating esophagus cancer |
| 08/29/2012 | CN102649961A Aptamer sequence of hepatitis B virus (HBV) core antigen and application of nucleic aptamer sequence |